论文部分内容阅读
目的:评价不同药物治疗方案在缺血性脑梗死治疗中的临床疗效及经济学效果。方法:60例缺血性脑梗死患者随机分为银杏达莫组与舒血宁组,每组30例,在常规疗法的基础上,分别给予银杏达莫注射液、舒血宁注射液静脉滴注,运用成本-效果分析法进行分析和比较。结果:银杏达莫组与舒血宁组的成本分别为10773.53、10935.43元,总有效率分别为83.33%、76.67%(P>0.05),成本-效果比分别为12928.75、14262.98。2组各出现1例消化道出血,经治疗痊愈,未见颅内出血者。结论:银杏达莫组方案较佳。
Objective: To evaluate the clinical effects and economic effects of different drug regimens in the treatment of ischemic cerebral infarction. Methods: Sixty patients with ischemic cerebral infarction were randomly divided into two groups: 30 cases in each group. Each group was given ginkgo dipyridamole injection and shuxuening injection intravenously Note, the use of cost-effectiveness analysis for analysis and comparison. Results: The costs of Yinxingdamo group and Shuxuening group were 10773.53,10935.43 yuan, the total effective rates were 83.33% and 76.67% (P> 0.05), respectively, and the cost-effectiveness ratios were 12928.75 and 14262.98.2 respectively 1 case of gastrointestinal bleeding, healed by treatment, no intracranial hemorrhage. Conclusion: Ginkgo biloba group scheme is better.